Healthcare Realty Trust Reports Results for the First Quarter

Rhea-AI Summary

Healthcare Realty Trust Incorporated (NYSE:HR) reported a net loss of $87.1 million, or $0.23 per diluted common share, for the first quarter of 2023. Normalized FFO for the same period was $152.8 million, or $0.40 per diluted common share. Same store cash NOI increased by 2.8% compared to the prior year. The company closed $96.0 million of asset sales since January 31st and expects to generate over $100 million in proceeds from loan repayment and sale of skilled nursing facilities in the next twelve months.

Positive

• Same store cash NOI increased by 2.8% over the prior year.
• The company closed $96.0 million of asset sales since January 31st.
• The company expects to generate over $100 million in proceeds from loan repayment and sale of skilled nursing facilities in the next twelve months.

Negative

• The company reported a net loss of $87.1 million for the first quarter.
• The company reserved $2.4 million of first quarter revenue related to Legacy HTA assets.
• The company recorded an allowance for credit loss of $5.2 million against the mezzanine loan principal balance.

NASHVILLE, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the first quarter ended March 31, 2023. The Company reported net loss attributable to common stockholders of $87.1 million, or $0.23 per diluted common share, for the quarter ended March 31, 2023. Normalized FFO for the three months ended March 31, 2023 totaled $152.8 million, or $0.40 per diluted common share.

Salient quarterly highlights include:

• Normalized FFO per share totaled $0.40.
• Same store cash NOI, including the Company's share of joint ventures, for the first quarter increased 2.8% over the prior year. For the trailing twelve months ended March 31, 2023, same store cash NOI, including the Company's share of joint ventures, grew 2.9%.
• Predictive growth measures in the same store portfolio include:
  • Average in-place rent increases of 2.7%
  • Future annual contractual increases of 2.9% for leases commencing in the quarter.
  • Weighted average cash leasing spreads of 3.1% on 954,000 square feet renewed:
    • 7% (<0% spread)
    • 22% (0-3%)
    • 52% (3-4%)
    • 19% (>4%)
  • Tenant retention of 82.3%
  • Year-over-year absorption of 150,000 square feet resulted in an average occupancy increase of 50 basis points, to 89.0%.
• Portfolio leasing activity in the first quarter totaled 1,463,000 square feet related to 338 leases:
  • 1,039,000 square feet of renewals
  • 424,000 square feet of new and expansion leases
• Since January 31st, the Company has closed $96.0 million of asset sales. Year-to-date, the Company closed joint ventures and asset sale transactions totaling $208.8 million at a weighted average cap rate of 6.5%.
• The Company reserved $2.4 million, or approximately $0.01 per share, of first quarter revenue related to Legacy HTA assets more fully described below.
  • The Company reserved $1.5 million of rental income for three skilled nursing facilities in Florida, and $0.9 million in interest income due under a $54.1 million mezzanine construction loan for a project in Houston.
  • In addition, the Company recorded an allowance for credit loss of $5.2 million against the mezzanine loan principal balance and $3.4 million for previously deferred rent from the skilled nursing facilities. The Company normalized for the non-cash charges related to these balance sheet allowances.
  • The Company expects to generate in excess of $100 million in proceeds over the next twelve months from the repayment of the loan and the sale of the skilled nursing facilities.
  • The Company does not have any additional mezzanine loans or skilled nursing facilities in the portfolio.
• In March, the Company acquired an outpatient medical facility in Tampa, FL totaling 116,000 square feet for $31.5 million at a 6.6% cap rate. This building is adjacent to the 465-bed BayCare St. Joseph's Hospital. The Company now owns three buildings totaling 172,000 square feet in this cluster.
• In the first quarter, the Company entered into new interest rate swaps totaling $150 million at a weighted average rate of 3.8%. In January, $300 million of interest rate swaps expired.
• Net debt to adjusted EBITDA was 6.6 times at the end of the quarter. Leverage is expected to decline from additional asset sales and underlying portfolio NOI growth.
• A dividend of $0.31 per share was paid in March, which equaled 95% of FAD. For the trailing twelve months, quarterly dividends paid equaled 97% of FAD. A dividend of $0.31 per share will be paid on June 2, 2023 to stockholders and OP unitholders of record on May 16, 2023.
• On Tuesday, May 9, 2023, at 10:00 a.m. Central Time, Healthcare Realty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends. Simultaneously, a webcast of the conference call will be available to interested parties at www.healthcarerealty.com under the Investor Relations section. A webcast replay will be available following the call at the same address. Conference Call Access Details: Domestic Dial-In Number: +1 833-470-1428 access code 420531; All Other Locations: +1 404-975-4839 access code 420531. Replay Information: Domestic Dial-In Number: 866-813-9403 access code 380939; All Other Locations: +1 929-458-6194 access code 380939

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of March 31, 2023, the Company was invested in over 700 real estate properties totaling more than 40 million square feet and provided leasing and property management services to over 35 million square feet nationwide.

Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, without limitation, the following: failure to realize the expected benefits of the Merger; significant transaction costs and/or unknown or inestimable liabilities; the risk that HTA’s business will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; general adverse economic and local real estate conditions; changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in the Company’s proposed market areas; changes in accounting principles generally accepted in the US; policies and guidelines applicable to REITs; the availability of properties to acquire; the availability of financing; pandemics and other health concerns, and the measures intended to prevent their spread, including the currently ongoing COVID-19 pandemic; and the potential material adverse effect these matters may have on the Company’s business, results of operations, cash flows and financial condition. Additional information concerning the Company and its business, including additional factors that could materially and adversely affect the Company’s financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in the Company’s 2022 Annual Report on Form 10-K and in its other filings with the SEC.

Consolidated Balance Sheets1
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
ASSETS
	1Q 2023			4Q 2022			3Q 2022
Real estate properties
Land	$	1,412,805		$	1,439,798		$	1,449,550
Buildings and improvements		11,196,297			11,332,037			11,439,797
Lease intangibles		929,008			959,998			968,914
Personal property		11,945			11,907			11,680
Investment in financing receivables, net		120,692			120,236			118,919
Financing lease right-of-use assets		83,420			83,824			79,950
Construction in progress		42,615			35,560			43,148
Land held for development		69,575			74,265			73,321
Total real estate investments		13,866,357			14,057,625			14,185,279
Less accumulated depreciation and amortization		(1,810,093	)		(1,645,271	)		(1,468,736	)
Total real estate investments, net		12,056,264			12,412,354			12,716,543
Cash and cash equivalents		49,941			60,961			57,583
Assets held for sale, net		3,579			18,893			185,074
Operating lease right-of-use assets		336,112			336,983			321,365
Investments in unconsolidated joint ventures		327,746			327,248			327,752
Other assets, net and goodwill		795,242			693,192			587,126
Total assets	$	13,568,884		$	13,849,631		$	14,195,443
LIABILITIES AND STOCKHOLDERS' EQUITY
	1Q 2023			4Q 2022			3Q 2022
Liabilities
Notes and bonds payable	$	5,361,699		$	5,351,827		$	5,570,139
Accounts payable and accrued liabilities		155,210			244,033			231,018
Liabilities of properties held for sale		277			437			10,644
Operating lease liabilities		279,637			279,895			268,840
Financing lease liabilities		73,193			72,939			72,378
Other liabilities		232,029			218,668			203,398
Total liabilities		6,102,045			6,167,799			6,356,417
Redeemable non-controlling interests		2,000			2,014			—
Stockholders' equity
Preferred stock, $0.01 par value; 200,000 shares authorized		—			—			—
Common stock, $0.01 par value; 1,000,000 shares authorized		3,808			3,806			3,806
Additional paid-in capital		9,591,194			9,587,637			9,586,556
Accumulated other comprehensive income (loss)		(8,554	)		2,140			5,524
Cumulative net income attributable to common stockholders		1,219,930			1,307,055			1,342,819
Cumulative dividends1		(3,447,750	)		(3,329,562	)		(3,211,492	)
Total stockholders' equity		7,358,628			7,571,076			7,727,213
Non-controlling interest		106,211			108,742			111,813
Total Equity		7,464,839			7,679,818			7,839,026
Total liabilities and stockholders' equity	$	13,568,884		$	13,849,631		$	14,195,443

1. Includes Legacy HTA's cumulative dividends in excess of earnings.
   

Consolidated Statements of Income
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
	1Q 2023			4Q 2022
Revenues
Rental income	$	324,093		$	329,399
Interest income		4,214			4,227
Other operating		4,618			4,436
		332,925			338,062
Expenses
Property operating		122,040			117,009
General and administrative		14,935			14,417
Acquisition and pursuit costs1		287			92
Merger-related costs		4,855			10,777
Depreciation and amortization		184,479			185,275
		326,596			327,570
Other income (expense)
Interest expense before merger-related fair value		(52,895	)		(52,464	)
Merger-related fair value adjustment		(10,864	)		(11,979	)
Interest expense		(63,759	)		(64,443	)
Gain on sales of real estate properties		1,007			73,083
Gain (loss) on extinguishment of debt		—			119
Impairment of real estate assets and credit loss reserves		(31,422	)		(54,452	)
Equity(loss) gain from unconsolidated joint ventures		(780	)		89
Interest and other income (expense), net		547			(1,168	)
		(94,407	)		(46,772	)
Net (loss) income	$	(88,078	)	$	(36,280	)
Net loss (income) attributable to non-controlling interests		953			516
Net (loss) income attributable to common stockholders	$	(87,125	)	$	(35,764	)
Basic earnings per common share	$	(0.23	)	$	(0.10	)
Diluted earnings per common share	$	(0.23	)	$	(0.10	)
Weighted average common shares outstanding - basic		378,840			378,617
Weighted average common shares outstanding - diluted2		378,840			378,617

1. Includes third party and travel costs related to the pursuit of acquisitions and developments.
2. Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount. As a result, the Company's OP totaling 4,042,993 units was not included.

Reconciliation of FFO, Normalized FFO and FAD1,2,3
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
	1Q 2023			4Q 2022
Net (loss) income attributable to common stockholders	$	(87,125	)	$	(35,764	)
Net (loss) income attributable to common stockholders per share3	$	(0.23	)	$	(0.10	)
Gain on sales of real estate assets		(1,007	)		(73,083	)
Impairments of real estate assets		26,227			54,452
Real estate depreciation and amortization		186,109			186,658
Non-controlling (loss) income from partnership units		(1,067	)		(382	)
Unconsolidated JV depreciation and amortization		4,841			4,020
FFO adjustments	$	215,103		$	171,665
FFO adjustments per common share - diluted	$	0.56		$	0.45
FFO	$	127,978		$	135,901
FFO per common share - diluted	$	0.33		$	0.35
Acquisition and pursuit costs		287			92
Merger-related costs		4,855			10,777
Lease intangible amortization		146			137
Non-routine legal costs/forfeited earnest money received		—			194
Debt financing costs		—			625
Allowance for credit losses4		8,599			—
Merger-related fair value adjustment		10,864			11,979
Unconsolidated JV normalizing items5		117			96
Normalized FFO adjustments	$	24,868		$	23,900
Normalized FFO adjustments per common share - diluted	$	0.06		$	0.06
Normalized FFO	$	152,846		$	159,801
Normalized FFO per common share - diluted	$	0.40		$	0.42
Non-real estate depreciation and amortization		604			624
Non-cash interest amortization, net6		682			2,284
Rent reserves, net		1,371			(100	)
Straight-line rent income, net		(8,246	)		(9,873	)
Stock-based compensation		3,745			3,573
Unconsolidated JV non-cash items7		(227	)		(316	)
Normalized FFO adjusted for non-cash items		150,775			155,993
2nd generation TI		(8,882	)		(13,523	)
Leasing commissions paid		(7,013	)		(7,404	)
Capital expenditures		(8,946	)		(25,669	)
Total maintenance capex		(24,841	)		(46,596	)
FAD	$	125,934		$	109,397
Quarterly dividends	$	119,442		$	119,323
FFO wtd avg common shares outstanding - diluted8		383,335			383,228

1. Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by the NAREIT. NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.”
2. FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.
3. Potential common shares are not included in the computation of diluted earnings per share when a loss exists as the effect would be an antidilutive per share amount.
4. Includes a $5.2 million credit allowance for a mezzanine loan included in "Impairment of real estate and credit loss reserves" on the Statement of Income and $3.4 million reserve included in “Rental Income” on the Statement of Income for previously deferred rent and straight line rent for three skilled nursing facilities.
5. Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.
6. Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.
7. Includes the Company's proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.
8. The Company utilizes the treasury stock method which includes the dilutive effect of nonvested share-based awards outstanding of 401,937 for the three months ended March 31, 2023. Also includes the diluted impact of 4,042,993 OP units outstanding.
   

Reconciliation of Non-GAAP Measures

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED

Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.

The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.

FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.

Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.

Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income and less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, tenant improvement amortization and leasing commission amortization. Cash NOI is historical and not necessarily indicative of future results.

Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.

The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures. These properties are described in additional detail in Footnote 6 to the Condensed Consolidated Financial Statements.

Any recently acquired property will be included in the same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the same store pool eight full quarters after substantial completion.

Ron Hubbard
Vice President, Investor Relations
P: 615.269.8290

FAQ

What were the financial results for Healthcare Realty Trust in the first quarter of 2023?

Healthcare Realty Trust reported a net loss of $87.1 million, or $0.23 per diluted common share, for the first quarter of 2023.

What was the Normalized FFO for the first quarter of 2023?

The Normalized FFO for the first quarter of 2023 was $152.8 million, or $0.40 per diluted common share.

Did the company experience any growth in same store cash NOI?

Yes, same store cash NOI increased by 2.8% over the prior year.

What asset sales did the company close since January 31st?

The company closed $96.0 million of asset sales since January 31st.

What is the company's expectation for proceeds from loan repayment and sale of skilled nursing facilities?

The company expects to generate over $100 million in proceeds from loan repayment and sale of skilled nursing facilities in the next twelve months.